EC
MEDP icon

Elequin Capital’s Medpace MEDP Stock Holding History

Elequin Capital’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6K Buy
+20
New +$9.23K ﹤0.01% 449

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Elequin Capital's MEDP Position: Q2 2026 in Review

Elequin Capital opened a new position in Medpace (MEDP) in Q2 2026: 20 shares worth $10.6K. The stake represents ﹤0.01% of the portfolio and ranks #449 among its holdings.

693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Elequin Capital held 20 shares of Medpace worth $10.6K as of Q2 2026.
  • Medpace was a new Elequin Capital position in Q2 2026.
  • Medpace made up ﹤0.01% of Elequin Capital's portfolio in Q2 2026, its #449 holding.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.